Regency Capital Management Inc.\De Eli Lilly & CO Transaction History

Regency Capital Management Inc.\De

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$224.85 - $279.04 $38,224 - $47,436	-170 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $37,672 - $46,360	170 New	170 $39,000
Q2 2021 Jul 07, 2021	SELL	$180.55 - $233.54 $272,630 - $352,645	-1,510 Closed	0 $0
Q1 2021 May 25, 2021	BUY	$164.32 - $212.72 $248,123 - $321,207	1,510 New	1,510 $282,000

3,871

751M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $840B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Regency Capital Management Inc.\De, based on Form 13F filings with the SEC.

Stay updated on Regency Capital Management Inc.\De with notifications on news.